In this study, we reanalysed single-cell RNA sequencing data from MS patients and revealed significant upregulation of MYD88 in DCs and CD4<sup>+</sup> T cells isolated from PBMCs of MS patients. This evidence concerns the gene CD4 and myeloid sarcoma.